UTZ BRANDS INC (UTZ)

US9180901012 - Common Stock

18.23  +0.13 (+0.72%)

After market: 18.23 0 (0%)

Fundamental Rating

3

Overall UTZ gets a fundamental rating of 3 out of 10. We evaluated UTZ against 93 industry peers in the Food Products industry. UTZ may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, UTZ is valued expensive at the moment.



3

1. Profitability

1.1 Basic Checks

UTZ had positive earnings in the past year.
UTZ had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: UTZ reported negative net income in multiple years.
Of the past 5 years UTZ 4 years had a positive operating cash flow.

1.2 Ratios

With a Return On Assets value of -0.75%, UTZ perfoms like the industry average, outperforming 44.57% of the companies in the same industry.
The Return On Equity of UTZ (-2.95%) is comparable to the rest of the industry.
UTZ's Return On Invested Capital of 1.16% is in line compared to the rest of the industry. UTZ outperforms 44.57% of its industry peers.
UTZ had an Average Return On Invested Capital over the past 3 years of 0.40%. This is significantly below the industry average of 7.83%.
The 3 year average ROIC (0.40%) for UTZ is below the current ROIC(1.16%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.75%
ROE -2.95%
ROIC 1.16%
ROA(3y)-0.05%
ROA(5y)-0.43%
ROE(3y)-0.25%
ROE(5y)-3.27%
ROIC(3y)0.4%
ROIC(5y)N/A

1.3 Margins

UTZ's Operating Margin of 2.45% is in line compared to the rest of the industry. UTZ outperforms 54.35% of its industry peers.
UTZ's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 32.90%, UTZ is doing good in the industry, outperforming 79.35% of the companies in the same industry.
UTZ's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.45%
PM (TTM) N/A
GM 32.9%
OM growth 3Y-17.64%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.65%
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so UTZ is destroying value.
UTZ has more shares outstanding than it did 1 year ago.
UTZ has more shares outstanding than it did 5 years ago.
UTZ has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 1.25, we must say that UTZ is in the distress zone and has some risk of bankruptcy.
UTZ's Altman-Z score of 1.25 is on the low side compared to the rest of the industry. UTZ is outperformed by 66.30% of its industry peers.
The Debt to FCF ratio of UTZ is 38.10, which is on the high side as it means it would take UTZ, 38.10 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 38.10, UTZ is in line with its industry, outperforming 50.00% of the companies in the same industry.
A Debt/Equity ratio of 1.13 is on the high side and indicates that UTZ has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.13, UTZ is doing worse than 72.83% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.13
Debt/FCF 38.1
Altman-Z 1.25
ROIC/WACC0.15
WACC7.65%

2.3 Liquidity

UTZ has a Current Ratio of 1.40. This is a normal value and indicates that UTZ is financially healthy and should not expect problems in meeting its short term obligations.
UTZ has a Current ratio (1.40) which is comparable to the rest of the industry.
A Quick Ratio of 0.95 indicates that UTZ may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.95, UTZ is in line with its industry, outperforming 59.78% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.4
Quick Ratio 0.95

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 9.09% over the past year.
UTZ shows a small growth in Revenue. In the last year, the Revenue has grown by 1.02%.
The Revenue has been growing by 14.25% on average over the past years. This is quite good.
EPS 1Y (TTM)9.09%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q27.27%
Revenue 1Y (TTM)1.02%
Revenue growth 3Y14.25%
Revenue growth 5YN/A
Revenue growth Q2Q-1.39%

3.2 Future

Based on estimates for the next years, UTZ will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.11% on average per year.
Based on estimates for the next years, UTZ will show a small growth in Revenue. The Revenue will grow by 4.11% on average per year.
EPS Next Y18.08%
EPS Next 2Y17.59%
EPS Next 3Y17.11%
EPS Next 5YN/A
Revenue Next Year-0.34%
Revenue Next 2Y1.7%
Revenue Next 3Y2.81%
Revenue Next 5Y4.11%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 30.38, which means the current valuation is very expensive for UTZ.
UTZ's Price/Earnings ratio is in line with the industry average.
UTZ is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.83, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 23.13, which indicates a rather expensive current valuation of UTZ.
Compared to the rest of the industry, the Price/Forward Earnings ratio of UTZ indicates a somewhat cheap valuation: UTZ is cheaper than 63.04% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 20.47. UTZ is around the same levels.
Industry RankSector Rank
PE 30.38
Fwd PE 23.13

4.2 Price Multiples

UTZ's Enterprise Value to EBITDA is on the same level as the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as UTZ.
Industry RankSector Rank
P/FCF 124.74
EV/EBITDA 29.1

4.3 Compensation for Growth

UTZ's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
UTZ's earnings are expected to grow with 17.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.68
PEG (5Y)N/A
EPS Next 2Y17.59%
EPS Next 3Y17.11%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.28%, UTZ has a reasonable but not impressive dividend return.
UTZ's Dividend Yield is a higher than the industry average which is at 3.55.
Compared to an average S&P500 Dividend Yield of 2.34, UTZ's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.28%

5.2 History

UTZ has been paying a dividend for over 5 years, so it has already some track record.
UTZ has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years3
Div Non Decr Years3

5.3 Sustainability

The earnings of UTZ are negative and hence is the payout ratio. UTZ will probably not be able to sustain this dividend level.
DP-93.65%
EPS Next 2Y17.59%
EPS Next 3Y17.11%

UTZ BRANDS INC

NYSE:UTZ (5/16/2024, 7:23:28 PM)

After market: 18.23 0 (0%)

18.23

+0.13 (+0.72%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.57B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 1.28%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 30.38
Fwd PE 23.13
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.68
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.75%
ROE -2.95%
ROCE
ROIC
ROICexc
ROICexgc
OM 2.45%
PM (TTM) N/A
GM 32.9%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 1.13
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.4
Quick Ratio 0.95
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)9.09%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y18.08%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)1.02%
Revenue growth 3Y14.25%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y